Statistics from Altmetric.com
Prostatitis represents the most frequent urological diagnosis in men below 50 years of age and the third most common diagnosis among individuals beyond that age.1 Chronic prostatitis (CP) syndromes are traditionally classified as bacterial or abacterial. CP/chronic pelvic pain syndrome (CPPS) (National Institutes of Health (NIH) category III) is diagnosed when patients show signs and symptoms of prostatitis and pelvic pain without evidence of prostatic bacterial infection. Years of clinical research failed to discover a single aetiological factor for CP/CPPS. Therefore, therapy for CP/CPPS is essentially symptomatic and involves the use of antibacterial agents, α-blockers, anti-inflammatory drugs, phytotherapy and so on – alone or in combination.
MEDLINE and EMBASE databases were searched for randomised controlled trials (RCTs) in which patients met NIH criteria for CP/CPPS. Studies were required to compare placebo with one of the following interventions: α-blockers, antibiotics, steroidal/non-steroidal anti-inflammatory drugs, finasteride, glycosminoglycans, phytotherapy and gabapentinoids. Outcomes …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.